BC
IMGN

BIT Capital’s Immunogen Inc IMGN Stock Holding History

BIT Capital’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-212,852
Closed -$3.38M – 147
2023
Q3 		$3.38M Buy
212,852
+4,397
+2% +$73.1K 0.4% 36
2023
Q2 		$3.93M Buy
208,455
+176,325
+549% +$2.08M 0.36% 37
2023
Q1 		$123K Buy
+32,130
New +$137K 0.02% 122
2022
Q3 		– Sell
-66,700
Closed -$300K – 178
2022
Q2 		$300K Sell
66,700
-7,000
-9% -$30.4K 0.04% 85
2022
Q1 		$351K Buy
+73,700
New +$408K 0.03% 90

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

BIT Capital's IMGN Position: Q4 2023 in Review

BIT Capital sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 212,852 shares — an estimated $3.38M sold.

BIT Capital first reported a position in IMGN in Q1 2022 and held it in 5 quarters. The position peaked at $3.93M in Q2 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • BIT Capital reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • BIT Capital sold 212,852 Immunogen Inc shares in Q4 2023, an estimated $3.38M.
  • BIT Capital first reported a position in Immunogen Inc in Q1 2022 and held it in 5 quarters.
  • BIT Capital's Immunogen Inc position peaked at $3.93M in Q2 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on BIT Capital's 13F filing for Q4 2023, filed 12 Feb 2025.